Gabrielle Masson

3 days ago | fiercebiotech.com | Gabrielle Masson |Darren Incorvaia

The National Institutes of Health (NIH) is rolling out rules that block new grants for any researcher or institution advancing programs related to diversity, equity and inclusion (DEI). The new rule also prohibits grant recipients from participating in boycotts against Israel, which includes cutting off or limiting commercial activity with Israeli companies. The new “Civils Rights term” applies to all current terms and conditions for NIH grants, according to an April 21 notice.

3 days ago | fiercebiotech.com | Gabrielle Masson |Darren Incorvaia

The National Institutes of Health (NIH) is halting new grant and contract payments to several universities, a move the agency has been instructed not to disclose to affected schools, according to several reports. Disbursements have been halted to Harvard University, Brown University, Northwestern University and Cornell University, plus Weill-Cornell Medical School, according to an April 16 NIH email viewed by Science.

1 week ago | fiercebiotech.com | Gabrielle Masson

Amid an FDA overhaul and market volatility, one biotech executive says her public company still operates with the mentality of a private company, while urging the industry to work together with federal health agencies so drug developers can continue to transform cancer care. “We were probably one of the lucky few that was able to go out last fall and have such a strong and successful IPO,” Bicara CEO Claire Mazumdar, Ph.D., told Fierce Biotech at the end of last week.

1 week ago | fiercebiotech.com | Ayla Ellison |Gabrielle Masson |Andrea Park

Welcome! In order to deliver a personalized and enhanced site navigation, we store information on how you use the site. We want you to know that we respect your privacy and your right to control how we collect and use your personal data. For more information, please see the Questex Privacy PolicyManage my cookie preferences

2 weeks ago | fiercehealthcare.com | Noah Tong |Gabrielle Masson

As the Trump administration continues to gut federal health agencies, several professional health and advocacy groups are speaking out, calling for the restoration of certain offices while warning of life-threatening consequences—with one organization even urging Secretary Robert F. Kennedy Jr. to step down.